Blepharoptosis (Ptosis) Treatment
What is Blepharoptosis (Ptosis)?
Ptosis is known as the drooping of the upper eyelid, and the patient usually presents with the complaint of the defect in vision and cosmesis. It can be congenital or acquired, or it can be neurogenic, myogenic, aponeurotic, mechanical, or traumatic in origin.
What is UPNEEQ?
UPNEEQ ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a FDA-approved prescription eyedrop used to treat acquired blepharoptosis (low-lying lids) in adults.
What should my doctor know about before prescribing me UPNEEQ?
- Your doctor should review your full medical history before prescribing UPNEEQ.
- UPNEEQ belongs to a class of medication (alpha-adrenergic agonists) that may affect your blood pressure. Use UPNEEQ carefully if you currently take an alpha-adrenergic agonist medication to treat heart disease or an enlarged prostate. Patients taking beta-blockers, or other medications to treat hypertension or an abnormal heartbeat, should also be careful when using UPNEEQ.
- Patients who use a certain class of antidepressant medication (monoamine oxidase inhibitors) should also be careful when using UPNEEQ, as it may affect the way your body absorbs the medication.